Relypsa Inc

FDA Filings

This page includes the latest FDA filings for Relypsa Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Filings

Device Company	Device	Date
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2023-12-06
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2023-04-11
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2022-12-17
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2022-01-06
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2021-12-07
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2021-05-29
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2020-12-02
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2019-12-27
VELTASSA Vifor Pharma, Inc.	Prescription Medication	2018-05-10
NDC 53436-252 Relypsa, Inc.	VELTASSA	2015-10-23
NDC 53436-168 Relypsa, Inc.	VELTASSA	2015-10-23
NDC 53436-084 Relypsa, Inc.	VELTASSA	2015-10-23
205739 NDA RELYPSA INC		0000-00-00 00:00:00

Similar & Related FDA Registered Companies

• Vifor Pharma, Inc.

Related Finance Registrations

NCAGE Code	7GPD7	RELYPSA, INC.
CAGE Code	7GPD7	RELYPSA, INC.
S.A.M. Registration	7GPD7 [808446087]	RELYPSA, INC.
SEC	0001416792	Relypsa Inc